nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—NR3C1—epilepsy syndrome	0.374	1	CbGaD
Mometasone—CYP2C8—Trimethadione—epilepsy syndrome	0.0716	0.17	CbGbCtD
Mometasone—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0673	0.16	CbGbCtD
Mometasone—CYP2C8—Carbamazepine—epilepsy syndrome	0.0484	0.115	CbGbCtD
Mometasone—CYP2C8—Primidone—epilepsy syndrome	0.0452	0.107	CbGbCtD
Mometasone—CYP2C8—Phenytoin—epilepsy syndrome	0.0434	0.103	CbGbCtD
Mometasone—CYP2C8—Propofol—epilepsy syndrome	0.0405	0.0962	CbGbCtD
Mometasone—CYP2C8—Phenobarbital—epilepsy syndrome	0.0387	0.0919	CbGbCtD
Mometasone—CYP2C8—Diazepam—epilepsy syndrome	0.0367	0.0872	CbGbCtD
Mometasone—CYP2C8—Valproic Acid—epilepsy syndrome	0.0289	0.0687	CbGbCtD
Mometasone—CYP2C8—Diclofenac Metabolic Pathway—CYP2C19—epilepsy syndrome	0.000786	0.0614	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SNIP1—epilepsy syndrome	0.00046	0.0359	CbGpPWpGaD
Mometasone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C19—epilepsy syndrome	0.000451	0.0353	CbGpPWpGaD
Mometasone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C19—epilepsy syndrome	0.000411	0.0321	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—FOSB—epilepsy syndrome	0.000358	0.028	CbGpPWpGaD
Mometasone—CYP2C8—CYP2E1 reactions—CYP2C19—epilepsy syndrome	0.00035	0.0273	CbGpPWpGaD
Mometasone—CYP2C8—CYP2E1 reactions—CYP2D6—epilepsy syndrome	0.000314	0.0245	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—DUSP5—epilepsy syndrome	0.000304	0.0237	CbGpPWpGaD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—epilepsy syndrome	0.000288	0.0225	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	0.000272	0.0212	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—KCNJ11—epilepsy syndrome	0.000236	0.0184	CbGpPWpGaD
Mometasone—CYP2C8—Xenobiotics—CYP2C19—epilepsy syndrome	0.000217	0.0169	CbGpPWpGaD
Mometasone—Prednisone—SLCO1A2—epilepsy syndrome	0.000212	0.0399	CrCbGaD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	0.000209	0.0163	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—DUSP4—epilepsy syndrome	0.000203	0.0158	CbGpPWpGaD
Mometasone—Prednisolone—SLCO1A2—epilepsy syndrome	0.000195	0.0368	CrCbGaD
Mometasone—CYP2C8—Xenobiotics—CYP2D6—epilepsy syndrome	0.000195	0.0152	CbGpPWpGaD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.000187	0.0146	CbGpPWpGaD
Mometasone—Difluprednate—NR3C1—epilepsy syndrome	0.000183	0.0346	CrCbGaD
Mometasone—Prednicarbate—NR3C1—epilepsy syndrome	0.000178	0.0335	CrCbGaD
Mometasone—Clocortolone—NR3C1—epilepsy syndrome	0.000178	0.0335	CrCbGaD
Mometasone—Diflorasone—NR3C1—epilepsy syndrome	0.000168	0.0317	CrCbGaD
Mometasone—Desonide—NR3C1—epilepsy syndrome	0.000168	0.0317	CrCbGaD
Mometasone—NR3C1—AP-1 transcription factor network—DUSP1—epilepsy syndrome	0.000164	0.0128	CbGpPWpGaD
Mometasone—Desoximetasone—NR3C1—epilepsy syndrome	0.000164	0.0309	CrCbGaD
Mometasone—Loteprednol—NR3C1—epilepsy syndrome	0.000162	0.0306	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	0.000156	0.0122	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	0.000156	0.0122	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—JUND—epilepsy syndrome	0.000153	0.0119	CbGpPWpGaD
Mometasone—Hydrocortisone—SLCO1A2—epilepsy syndrome	0.000149	0.0282	CrCbGaD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—epilepsy syndrome	0.000142	0.0111	CbGpPWpGaD
Mometasone—Flumethasone Pivalate—NR3C1—epilepsy syndrome	0.000141	0.0266	CrCbGaD
Mometasone—Halobetasol Propionate—NR3C1—epilepsy syndrome	0.000139	0.0262	CrCbGaD
Mometasone—NR3C1—Nuclear Receptors—VDR—epilepsy syndrome	0.000135	0.0105	CbGpPWpGaD
Mometasone—Body temperature increased—Felbamate—epilepsy syndrome	0.000129	0.000691	CcSEcCtD
Mometasone—Abdominal pain—Felbamate—epilepsy syndrome	0.000129	0.000691	CcSEcCtD
Mometasone—Vomiting—Acetazolamide—epilepsy syndrome	0.000129	0.000691	CcSEcCtD
Mometasone—Diarrhoea—Propofol—epilepsy syndrome	0.000129	0.00069	CcSEcCtD
Mometasone—Amcinonide—NR3C1—epilepsy syndrome	0.000129	0.0244	CrCbGaD
Mometasone—Budesonide—NR3C1—epilepsy syndrome	0.000129	0.0244	CrCbGaD
Mometasone—Immune system disorder—Pregabalin—epilepsy syndrome	0.000129	0.00069	CcSEcCtD
Mometasone—Pruritus—Levetiracetam—epilepsy syndrome	0.000129	0.00069	CcSEcCtD
Mometasone—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000129	0.000689	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000129	0.000688	CcSEcCtD
Mometasone—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000129	0.000688	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK10—epilepsy syndrome	0.000129	0.0101	CbGpPWpGaD
Mometasone—Upper respiratory tract infection—Topiramate—epilepsy syndrome	0.000128	0.000684	CcSEcCtD
Mometasone—Headache—Acetazolamide—epilepsy syndrome	0.000127	0.000681	CcSEcCtD
Mometasone—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—epilepsy syndrome	0.000127	0.00994	CbGpPWpGaD
Mometasone—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000127	0.00068	CcSEcCtD
Mometasone—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000127	0.000678	CcSEcCtD
Mometasone—Fluticasone furoate—NR3C1—epilepsy syndrome	0.000127	0.0239	CrCbGaD
Mometasone—Abdominal pain—Zonisamide—epilepsy syndrome	0.000127	0.000676	CcSEcCtD
Mometasone—Body temperature increased—Zonisamide—epilepsy syndrome	0.000127	0.000676	CcSEcCtD
Mometasone—Asthenia—Fosphenytoin—epilepsy syndrome	0.000126	0.000675	CcSEcCtD
Mometasone—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000126	0.000674	CcSEcCtD
Mometasone—Fatigue—Carbamazepine—epilepsy syndrome	0.000126	0.000674	CcSEcCtD
Mometasone—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000126	0.000674	CcSEcCtD
Mometasone—Angioedema—Valproic Acid—epilepsy syndrome	0.000126	0.000672	CcSEcCtD
Mometasone—Pain—Carbamazepine—epilepsy syndrome	0.000125	0.000668	CcSEcCtD
Mometasone—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000125	0.000667	CcSEcCtD
Mometasone—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000125	0.000666	CcSEcCtD
Mometasone—Pruritus—Fosphenytoin—epilepsy syndrome	0.000125	0.000666	CcSEcCtD
Mometasone—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000124	0.000665	CcSEcCtD
Mometasone—Asthenia—Vigabatrin—epilepsy syndrome	0.000123	0.000658	CcSEcCtD
Mometasone—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000123	0.000657	CcSEcCtD
Mometasone—Abdominal pain—Clonazepam—epilepsy syndrome	0.000122	0.000652	CcSEcCtD
Mometasone—Body temperature increased—Clonazepam—epilepsy syndrome	0.000122	0.000652	CcSEcCtD
Mometasone—Fatigue—Lamotrigine—epilepsy syndrome	0.000122	0.000651	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.000122	0.00949	CbGpPWpGaD
Mometasone—Pruritus—Vigabatrin—epilepsy syndrome	0.000121	0.000649	CcSEcCtD
Mometasone—Rimexolone—NR3C1—epilepsy syndrome	0.000121	0.0229	CrCbGaD
Mometasone—Asthenia—Diazepam—epilepsy syndrome	0.000121	0.000648	CcSEcCtD
Mometasone—Body temperature increased—Phenytoin—epilepsy syndrome	0.000121	0.000647	CcSEcCtD
Mometasone—Pain—Lamotrigine—epilepsy syndrome	0.000121	0.000646	CcSEcCtD
Mometasone—Nausea—Acetazolamide—epilepsy syndrome	0.000121	0.000645	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—MIF—epilepsy syndrome	0.000121	0.00942	CbGpPWpGaD
Mometasone—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000121	0.000644	CcSEcCtD
Mometasone—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000121	0.000644	CcSEcCtD
Mometasone—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.00012	0.000644	CcSEcCtD
Mometasone—Back pain—Pregabalin—epilepsy syndrome	0.00012	0.000643	CcSEcCtD
Mometasone—Cough—Valproic Acid—epilepsy syndrome	0.00012	0.000642	CcSEcCtD
Mometasone—Vomiting—Propofol—epilepsy syndrome	0.00012	0.000642	CcSEcCtD
Mometasone—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.00012	0.000639	CcSEcCtD
Mometasone—Pruritus—Diazepam—epilepsy syndrome	0.00012	0.000639	CcSEcCtD
Mometasone—Conjunctivitis—Topiramate—epilepsy syndrome	0.000119	0.000638	CcSEcCtD
Mometasone—Urinary tract infection—Topiramate—epilepsy syndrome	0.000119	0.000638	CcSEcCtD
Mometasone—Rash—Propofol—epilepsy syndrome	0.000119	0.000636	CcSEcCtD
Mometasone—Dermatitis—Propofol—epilepsy syndrome	0.000119	0.000636	CcSEcCtD
Mometasone—Immune system disorder—Gabapentin—epilepsy syndrome	0.000118	0.000633	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.000118	0.00925	CbGpPWpGaD
Mometasone—Headache—Propofol—epilepsy syndrome	0.000118	0.000632	CcSEcCtD
Mometasone—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000118	0.000631	CcSEcCtD
Mometasone—Vomiting—Midazolam—epilepsy syndrome	0.000117	0.000628	CcSEcCtD
Mometasone—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000117	0.000628	CcSEcCtD
Mometasone—Asthenia—Felbamate—epilepsy syndrome	0.000117	0.000627	CcSEcCtD
Mometasone—Arthralgia—Valproic Acid—epilepsy syndrome	0.000117	0.000626	CcSEcCtD
Mometasone—Chest pain—Valproic Acid—epilepsy syndrome	0.000117	0.000626	CcSEcCtD
Mometasone—Myalgia—Valproic Acid—epilepsy syndrome	0.000117	0.000626	CcSEcCtD
Mometasone—Rash—Midazolam—epilepsy syndrome	0.000116	0.000623	CcSEcCtD
Mometasone—Dermatitis—Midazolam—epilepsy syndrome	0.000116	0.000622	CcSEcCtD
Mometasone—Vomiting—Levetiracetam—epilepsy syndrome	0.000116	0.00062	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000116	0.00906	CbGpPWpGaD
Mometasone—Epistaxis—Topiramate—epilepsy syndrome	0.000116	0.000619	CcSEcCtD
Mometasone—Headache—Midazolam—epilepsy syndrome	0.000116	0.000619	CcSEcCtD
Mometasone—Pruritus—Felbamate—epilepsy syndrome	0.000116	0.000618	CcSEcCtD
Mometasone—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000116	0.000618	CcSEcCtD
Mometasone—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000116	0.000618	CcSEcCtD
Mometasone—Diarrhoea—Diazepam—epilepsy syndrome	0.000116	0.000618	CcSEcCtD
Mometasone—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000116	0.000618	CcSEcCtD
Mometasone—Sinusitis—Topiramate—epilepsy syndrome	0.000115	0.000616	CcSEcCtD
Mometasone—Rash—Levetiracetam—epilepsy syndrome	0.000115	0.000615	CcSEcCtD
Mometasone—Dermatitis—Levetiracetam—epilepsy syndrome	0.000115	0.000614	CcSEcCtD
Mometasone—Asthenia—Zonisamide—epilepsy syndrome	0.000115	0.000614	CcSEcCtD
Mometasone—Dry mouth—Valproic Acid—epilepsy syndrome	0.000115	0.000612	CcSEcCtD
Mometasone—Beclomethasone—NR3C1—epilepsy syndrome	0.000115	0.0216	CrCbGaD
Mometasone—Fluocinonide—NR3C1—epilepsy syndrome	0.000115	0.0216	CrCbGaD
Mometasone—Headache—Levetiracetam—epilepsy syndrome	0.000114	0.000611	CcSEcCtD
Mometasone—Angioedema—Pregabalin—epilepsy syndrome	0.000114	0.000608	CcSEcCtD
Mometasone—Pruritus—Zonisamide—epilepsy syndrome	0.000113	0.000605	CcSEcCtD
Mometasone—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000112	0.0006	CcSEcCtD
Mometasone—Nausea—Propofol—epilepsy syndrome	0.000112	0.000599	CcSEcCtD
Mometasone—Vomiting—Fosphenytoin—epilepsy syndrome	0.000112	0.000598	CcSEcCtD
Mometasone—Diarrhoea—Felbamate—epilepsy syndrome	0.000112	0.000598	CcSEcCtD
Mometasone—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000112	0.000597	CcSEcCtD
Mometasone—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000112	0.000597	CcSEcCtD
Mometasone—Infection—Valproic Acid—epilepsy syndrome	0.000112	0.000596	CcSEcCtD
Mometasone—Alclometasone—NR3C1—epilepsy syndrome	0.000111	0.021	CrCbGaD
Mometasone—Fluocinolone Acetonide—NR3C1—epilepsy syndrome	0.000111	0.021	CrCbGaD
Mometasone—Dexamethasone—SLCO1A2—epilepsy syndrome	0.000111	0.021	CrCbGaD
Mometasone—Rash—Fosphenytoin—epilepsy syndrome	0.000111	0.000593	CcSEcCtD
Mometasone—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000111	0.000593	CcSEcCtD
Mometasone—Asthenia—Clonazepam—epilepsy syndrome	0.000111	0.000592	CcSEcCtD
Mometasone—Rhinitis—Topiramate—epilepsy syndrome	0.000111	0.000591	CcSEcCtD
Mometasone—Back pain—Gabapentin—epilepsy syndrome	0.00011	0.00059	CcSEcCtD
Mometasone—Headache—Fosphenytoin—epilepsy syndrome	0.00011	0.000589	CcSEcCtD
Mometasone—Asthenia—Phenytoin—epilepsy syndrome	0.00011	0.000588	CcSEcCtD
Mometasone—Nausea—Midazolam—epilepsy syndrome	0.00011	0.000586	CcSEcCtD
Mometasone—Diarrhoea—Zonisamide—epilepsy syndrome	0.00011	0.000585	CcSEcCtD
Mometasone—Pharyngitis—Topiramate—epilepsy syndrome	0.000109	0.000585	CcSEcCtD
Mometasone—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000109	0.000584	CcSEcCtD
Mometasone—Pruritus—Clonazepam—epilepsy syndrome	0.000109	0.000583	CcSEcCtD
Mometasone—Vomiting—Vigabatrin—epilepsy syndrome	0.000109	0.000583	CcSEcCtD
Mometasone—Cough—Pregabalin—epilepsy syndrome	0.000109	0.00058	CcSEcCtD
Mometasone—Pruritus—Phenytoin—epilepsy syndrome	0.000108	0.000579	CcSEcCtD
Mometasone—Nausea—Levetiracetam—epilepsy syndrome	0.000108	0.000579	CcSEcCtD
Mometasone—Flunisolide—NR3C1—epilepsy syndrome	0.000108	0.0204	CrCbGaD
Mometasone—Fludrocortisone—NR3C1—epilepsy syndrome	0.000108	0.0204	CrCbGaD
Mometasone—Clobetasol propionate—NR3C1—epilepsy syndrome	0.000108	0.0204	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.000108	0.00846	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.000108	0.00846	CbGpPWpGaD
Mometasone—Rash—Vigabatrin—epilepsy syndrome	0.000108	0.000578	CcSEcCtD
Mometasone—Dermatitis—Vigabatrin—epilepsy syndrome	0.000108	0.000578	CcSEcCtD
Mometasone—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000108	0.000576	CcSEcCtD
Mometasone—Headache—Vigabatrin—epilepsy syndrome	0.000108	0.000575	CcSEcCtD
Mometasone—Vomiting—Diazepam—epilepsy syndrome	0.000107	0.000574	CcSEcCtD
Mometasone—Anorexia—Valproic Acid—epilepsy syndrome	0.000107	0.000572	CcSEcCtD
Mometasone—Paramethasone—NR3C1—epilepsy syndrome	0.000107	0.0202	CrCbGaD
Mometasone—Rash—Diazepam—epilepsy syndrome	0.000107	0.000569	CcSEcCtD
Mometasone—Dermatitis—Diazepam—epilepsy syndrome	0.000106	0.000569	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—VDR—epilepsy syndrome	0.000106	0.0083	CbGpPWpGaD
Mometasone—Chest pain—Pregabalin—epilepsy syndrome	0.000106	0.000566	CcSEcCtD
Mometasone—Myalgia—Pregabalin—epilepsy syndrome	0.000106	0.000566	CcSEcCtD
Mometasone—Arthralgia—Pregabalin—epilepsy syndrome	0.000106	0.000566	CcSEcCtD
Mometasone—Headache—Diazepam—epilepsy syndrome	0.000106	0.000566	CcSEcCtD
Mometasone—Diarrhoea—Clonazepam—epilepsy syndrome	0.000106	0.000564	CcSEcCtD
Mometasone—Asthenia—Carbamazepine—epilepsy syndrome	0.000105	0.000561	CcSEcCtD
Mometasone—Triamcinolone—BCHE—epilepsy syndrome	0.000105	0.0198	CrCbGaD
Mometasone—Diarrhoea—Phenytoin—epilepsy syndrome	0.000105	0.00056	CcSEcCtD
Mometasone—Nausea—Fosphenytoin—epilepsy syndrome	0.000105	0.000559	CcSEcCtD
Mometasone—NR3C1—Regulation of Androgen receptor activity—SIRT1—epilepsy syndrome	0.000105	0.00817	CbGpPWpGaD
Mometasone—Fluorometholone—NR3C1—epilepsy syndrome	0.000104	0.0197	CrCbGaD
Mometasone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000104	0.000557	CcSEcCtD
Mometasone—Angioedema—Gabapentin—epilepsy syndrome	0.000104	0.000557	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.000104	0.00814	CbGpPWpGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—CYP2C19—epilepsy syndrome	0.000104	0.00814	CbGpPWpGaD
Mometasone—Vomiting—Felbamate—epilepsy syndrome	0.000104	0.000556	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—JUNB—epilepsy syndrome	0.000104	0.00812	CbGpPWpGaD
Mometasone—Dry mouth—Pregabalin—epilepsy syndrome	0.000104	0.000554	CcSEcCtD
Mometasone—NR3C1—Circadian Clock—AVP—epilepsy syndrome	0.000104	0.00809	CbGpPWpGaD
Mometasone—Pruritus—Carbamazepine—epilepsy syndrome	0.000104	0.000553	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—TH—epilepsy syndrome	0.000103	0.00806	CbGpPWpGaD
Mometasone—Rash—Felbamate—epilepsy syndrome	0.000103	0.000551	CcSEcCtD
Mometasone—Dermatitis—Felbamate—epilepsy syndrome	0.000103	0.000551	CcSEcCtD
Mometasone—Headache—Felbamate—epilepsy syndrome	0.000102	0.000548	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000102	0.000547	CcSEcCtD
Mometasone—Nausea—Vigabatrin—epilepsy syndrome	0.000102	0.000545	CcSEcCtD
Mometasone—Vomiting—Zonisamide—epilepsy syndrome	0.000102	0.000544	CcSEcCtD
Mometasone—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000102	0.000543	CcSEcCtD
Mometasone—Asthenia—Lamotrigine—epilepsy syndrome	0.000101	0.000542	CcSEcCtD
Mometasone—Methylprednisolone—NR3C1—epilepsy syndrome	0.000101	0.019	CrCbGaD
Mometasone—Rash—Zonisamide—epilepsy syndrome	0.000101	0.000539	CcSEcCtD
Mometasone—Infection—Pregabalin—epilepsy syndrome	0.000101	0.000539	CcSEcCtD
Mometasone—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000101	0.000539	CcSEcCtD
Mometasone—Dermatitis—Zonisamide—epilepsy syndrome	0.000101	0.000539	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.000101	0.00786	CbGpPWpGaD
Mometasone—Nausea—Diazepam—epilepsy syndrome	0.0001	0.000536	CcSEcCtD
Mometasone—Headache—Zonisamide—epilepsy syndrome	0.0001	0.000536	CcSEcCtD
Mometasone—Dyspnoea—Valproic Acid—epilepsy syndrome	0.0001	0.000535	CcSEcCtD
Mometasone—Diarrhoea—Carbamazepine—epilepsy syndrome	0.0001	0.000535	CcSEcCtD
Mometasone—Pruritus—Lamotrigine—epilepsy syndrome	0.0001	0.000535	CcSEcCtD
Mometasone—Immune system disorder—Topiramate—epilepsy syndrome	9.96e-05	0.000532	CcSEcCtD
Mometasone—Cough—Gabapentin—epilepsy syndrome	9.96e-05	0.000532	CcSEcCtD
Mometasone—Mediastinal disorder—Topiramate—epilepsy syndrome	9.94e-05	0.000531	CcSEcCtD
Mometasone—Dyspepsia—Valproic Acid—epilepsy syndrome	9.89e-05	0.000528	CcSEcCtD
Mometasone—Vomiting—Clonazepam—epilepsy syndrome	9.81e-05	0.000524	CcSEcCtD
Mometasone—Decreased appetite—Valproic Acid—epilepsy syndrome	9.77e-05	0.000522	CcSEcCtD
Mometasone—Vomiting—Phenytoin—epilepsy syndrome	9.74e-05	0.000521	CcSEcCtD
Mometasone—Rash—Clonazepam—epilepsy syndrome	9.73e-05	0.00052	CcSEcCtD
Mometasone—Dermatitis—Clonazepam—epilepsy syndrome	9.72e-05	0.000519	CcSEcCtD
Mometasone—Arthralgia—Gabapentin—epilepsy syndrome	9.72e-05	0.000519	CcSEcCtD
Mometasone—Myalgia—Gabapentin—epilepsy syndrome	9.72e-05	0.000519	CcSEcCtD
Mometasone—Chest pain—Gabapentin—epilepsy syndrome	9.72e-05	0.000519	CcSEcCtD
Mometasone—Nausea—Felbamate—epilepsy syndrome	9.72e-05	0.000519	CcSEcCtD
Mometasone—Vomiting—Oxcarbazepine—epilepsy syndrome	9.69e-05	0.000518	CcSEcCtD
Mometasone—Fatigue—Valproic Acid—epilepsy syndrome	9.69e-05	0.000518	CcSEcCtD
Mometasone—Anorexia—Pregabalin—epilepsy syndrome	9.68e-05	0.000517	CcSEcCtD
Mometasone—Dexamethasone—CYP11A1—epilepsy syndrome	9.68e-05	0.0183	CrCbGaD
Mometasone—Diarrhoea—Lamotrigine—epilepsy syndrome	9.67e-05	0.000517	CcSEcCtD
Mometasone—Headache—Clonazepam—epilepsy syndrome	9.67e-05	0.000517	CcSEcCtD
Mometasone—Rash—Phenytoin—epilepsy syndrome	9.66e-05	0.000516	CcSEcCtD
Mometasone—Dermatitis—Phenytoin—epilepsy syndrome	9.65e-05	0.000516	CcSEcCtD
Mometasone—Rash—Oxcarbazepine—epilepsy syndrome	9.61e-05	0.000514	CcSEcCtD
Mometasone—Pain—Valproic Acid—epilepsy syndrome	9.61e-05	0.000513	CcSEcCtD
Mometasone—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.6e-05	0.000513	CcSEcCtD
Mometasone—Headache—Phenytoin—epilepsy syndrome	9.6e-05	0.000513	CcSEcCtD
Mometasone—Headache—Oxcarbazepine—epilepsy syndrome	9.55e-05	0.00051	CcSEcCtD
Mometasone—Nausea—Zonisamide—epilepsy syndrome	9.51e-05	0.000508	CcSEcCtD
Mometasone—Dry mouth—Gabapentin—epilepsy syndrome	9.5e-05	0.000508	CcSEcCtD
Mometasone—NR3C1—Circadian Clock—MEF2C—epilepsy syndrome	9.47e-05	0.0074	CbGpPWpGaD
Mometasone—Anaphylactic shock—Gabapentin—epilepsy syndrome	9.31e-05	0.000498	CcSEcCtD
Mometasone—Vomiting—Carbamazepine—epilepsy syndrome	9.3e-05	0.000497	CcSEcCtD
Mometasone—Back pain—Topiramate—epilepsy syndrome	9.29e-05	0.000496	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.25e-05	0.000494	CcSEcCtD
Mometasone—Infection—Gabapentin—epilepsy syndrome	9.25e-05	0.000494	CcSEcCtD
Mometasone—Rash—Carbamazepine—epilepsy syndrome	9.22e-05	0.000493	CcSEcCtD
Mometasone—Dermatitis—Carbamazepine—epilepsy syndrome	9.22e-05	0.000492	CcSEcCtD
Mometasone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.19e-05	0.000491	CcSEcCtD
Mometasone—Nausea—Clonazepam—epilepsy syndrome	9.17e-05	0.00049	CcSEcCtD
Mometasone—Headache—Carbamazepine—epilepsy syndrome	9.16e-05	0.00049	CcSEcCtD
Mometasone—Paraesthesia—Pregabalin—epilepsy syndrome	9.12e-05	0.000487	CcSEcCtD
Mometasone—Nausea—Phenytoin—epilepsy syndrome	9.1e-05	0.000486	CcSEcCtD
Mometasone—Dyspnoea—Pregabalin—epilepsy syndrome	9.06e-05	0.000484	CcSEcCtD
Mometasone—Nausea—Oxcarbazepine—epilepsy syndrome	9.06e-05	0.000484	CcSEcCtD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	9.01e-05	0.00703	CbGpPWpGaD
Mometasone—Vomiting—Lamotrigine—epilepsy syndrome	8.99e-05	0.00048	CcSEcCtD
Mometasone—Fluoxymesterone—NR3C1—epilepsy syndrome	8.95e-05	0.0169	CrCbGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	8.95e-05	0.00699	CbGpPWpGaD
Mometasone—Rash—Lamotrigine—epilepsy syndrome	8.91e-05	0.000476	CcSEcCtD
Mometasone—Dermatitis—Lamotrigine—epilepsy syndrome	8.91e-05	0.000476	CcSEcCtD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	8.89e-05	0.00694	CbGpPWpGaD
Mometasone—Body temperature increased—Valproic Acid—epilepsy syndrome	8.88e-05	0.000475	CcSEcCtD
Mometasone—Abdominal pain—Valproic Acid—epilepsy syndrome	8.88e-05	0.000475	CcSEcCtD
Mometasone—Anorexia—Gabapentin—epilepsy syndrome	8.88e-05	0.000474	CcSEcCtD
Mometasone—Headache—Lamotrigine—epilepsy syndrome	8.86e-05	0.000473	CcSEcCtD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	8.83e-05	0.0069	CbGpPWpGaD
Mometasone—Decreased appetite—Pregabalin—epilepsy syndrome	8.83e-05	0.000472	CcSEcCtD
Mometasone—Fatigue—Pregabalin—epilepsy syndrome	8.76e-05	0.000468	CcSEcCtD
Mometasone—Nausea—Carbamazepine—epilepsy syndrome	8.69e-05	0.000464	CcSEcCtD
Mometasone—Pain—Pregabalin—epilepsy syndrome	8.69e-05	0.000464	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	8.56e-05	0.00669	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	8.56e-05	0.00669	CbGpPWpGaD
Mometasone—Triamcinolone—NR3C1—epilepsy syndrome	8.51e-05	0.0161	CrCbGaD
Mometasone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.49e-05	0.000453	CcSEcCtD
Mometasone—Nausea—Lamotrigine—epilepsy syndrome	8.4e-05	0.000449	CcSEcCtD
Mometasone—Cough—Topiramate—epilepsy syndrome	8.38e-05	0.000448	CcSEcCtD
Mometasone—Paraesthesia—Gabapentin—epilepsy syndrome	8.36e-05	0.000447	CcSEcCtD
Mometasone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.31e-05	0.000444	CcSEcCtD
Mometasone—Dyspnoea—Gabapentin—epilepsy syndrome	8.3e-05	0.000444	CcSEcCtD
Mometasone—Dyspepsia—Gabapentin—epilepsy syndrome	8.2e-05	0.000438	CcSEcCtD
Mometasone—Myalgia—Topiramate—epilepsy syndrome	8.17e-05	0.000437	CcSEcCtD
Mometasone—Arthralgia—Topiramate—epilepsy syndrome	8.17e-05	0.000437	CcSEcCtD
Mometasone—Chest pain—Topiramate—epilepsy syndrome	8.17e-05	0.000437	CcSEcCtD
Mometasone—Decreased appetite—Gabapentin—epilepsy syndrome	8.1e-05	0.000433	CcSEcCtD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	8.08e-05	0.00631	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—BMP4—epilepsy syndrome	8.07e-05	0.00631	CbGpPWpGaD
Mometasone—Asthenia—Valproic Acid—epilepsy syndrome	8.06e-05	0.000431	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	8.05e-05	0.00629	CbGpPWpGaD
Mometasone—Fatigue—Gabapentin—epilepsy syndrome	8.03e-05	0.000429	CcSEcCtD
Mometasone—Body temperature increased—Pregabalin—epilepsy syndrome	8.03e-05	0.000429	CcSEcCtD
Mometasone—Abdominal pain—Pregabalin—epilepsy syndrome	8.03e-05	0.000429	CcSEcCtD
Mometasone—Dexamethasone—NOS2—epilepsy syndrome	8.02e-05	0.0151	CrCbGaD
Mometasone—Dry mouth—Topiramate—epilepsy syndrome	7.99e-05	0.000427	CcSEcCtD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	7.97e-05	0.00623	CbGpPWpGaD
Mometasone—Pain—Gabapentin—epilepsy syndrome	7.96e-05	0.000426	CcSEcCtD
Mometasone—Pruritus—Valproic Acid—epilepsy syndrome	7.95e-05	0.000425	CcSEcCtD
Mometasone—Infection—Topiramate—epilepsy syndrome	7.78e-05	0.000416	CcSEcCtD
Mometasone—Prednisone—NR3C1—epilepsy syndrome	7.72e-05	0.0146	CrCbGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—epilepsy syndrome	7.71e-05	0.00602	CbGpPWpGaD
Mometasone—Diarrhoea—Valproic Acid—epilepsy syndrome	7.69e-05	0.000411	CcSEcCtD
Mometasone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.62e-05	0.000407	CcSEcCtD
Mometasone—Fluticasone Propionate—NR3C1—epilepsy syndrome	7.61e-05	0.0144	CrCbGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—epilepsy syndrome	7.5e-05	0.00586	CbGpPWpGaD
Mometasone—Anorexia—Topiramate—epilepsy syndrome	7.47e-05	0.000399	CcSEcCtD
Mometasone—Abdominal pain—Gabapentin—epilepsy syndrome	7.36e-05	0.000393	CcSEcCtD
Mometasone—Body temperature increased—Gabapentin—epilepsy syndrome	7.36e-05	0.000393	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—epilepsy syndrome	7.34e-05	0.00573	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	7.3e-05	0.0057	CbGpPWpGaD
Mometasone—Asthenia—Pregabalin—epilepsy syndrome	7.29e-05	0.000389	CcSEcCtD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	7.26e-05	0.00567	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	7.23e-05	0.00564	CbGpPWpGaD
Mometasone—Pruritus—Pregabalin—epilepsy syndrome	7.19e-05	0.000384	CcSEcCtD
Mometasone—Vomiting—Valproic Acid—epilepsy syndrome	7.14e-05	0.000382	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.14e-05	0.000381	CcSEcCtD
Mometasone—Prednisolone—NR3C1—epilepsy syndrome	7.12e-05	0.0134	CrCbGaD
Mometasone—Rash—Valproic Acid—epilepsy syndrome	7.08e-05	0.000379	CcSEcCtD
Mometasone—Dermatitis—Valproic Acid—epilepsy syndrome	7.08e-05	0.000378	CcSEcCtD
Mometasone—Prednisone—CYP2C19—epilepsy syndrome	7.04e-05	0.0133	CrCbGaD
Mometasone—Headache—Valproic Acid—epilepsy syndrome	7.04e-05	0.000376	CcSEcCtD
Mometasone—Paraesthesia—Topiramate—epilepsy syndrome	7.04e-05	0.000376	CcSEcCtD
Mometasone—Dyspnoea—Topiramate—epilepsy syndrome	6.99e-05	0.000373	CcSEcCtD
Mometasone—Betamethasone—NR3C1—epilepsy syndrome	6.97e-05	0.0132	CrCbGaD
Mometasone—Diarrhoea—Pregabalin—epilepsy syndrome	6.95e-05	0.000371	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	6.95e-05	0.00543	CbGpPWpGaD
Mometasone—Dyspepsia—Topiramate—epilepsy syndrome	6.9e-05	0.000369	CcSEcCtD
Mometasone—Decreased appetite—Topiramate—epilepsy syndrome	6.81e-05	0.000364	CcSEcCtD
Mometasone—Fatigue—Topiramate—epilepsy syndrome	6.76e-05	0.000361	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—AGT—epilepsy syndrome	6.74e-05	0.00526	CbGpPWpGaD
Mometasone—Pain—Topiramate—epilepsy syndrome	6.7e-05	0.000358	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—PLAU—epilepsy syndrome	6.7e-05	0.00523	CbGpPWpGaD
Mometasone—Asthenia—Gabapentin—epilepsy syndrome	6.68e-05	0.000357	CcSEcCtD
Mometasone—Nausea—Valproic Acid—epilepsy syndrome	6.67e-05	0.000357	CcSEcCtD
Mometasone—Pruritus—Gabapentin—epilepsy syndrome	6.59e-05	0.000352	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	6.56e-05	0.00512	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	6.55e-05	0.00512	CbGpPWpGaD
Mometasone—Vomiting—Pregabalin—epilepsy syndrome	6.46e-05	0.000345	CcSEcCtD
Mometasone—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.41e-05	0.000342	CcSEcCtD
Mometasone—Rash—Pregabalin—epilepsy syndrome	6.4e-05	0.000342	CcSEcCtD
Mometasone—Dermatitis—Pregabalin—epilepsy syndrome	6.4e-05	0.000342	CcSEcCtD
Mometasone—Diarrhoea—Gabapentin—epilepsy syndrome	6.37e-05	0.000341	CcSEcCtD
Mometasone—Headache—Pregabalin—epilepsy syndrome	6.36e-05	0.00034	CcSEcCtD
Mometasone—Hydrocortisone—ABCG2—epilepsy syndrome	6.31e-05	0.0119	CrCbGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—GPX1—epilepsy syndrome	6.2e-05	0.00485	CbGpPWpGaD
Mometasone—Body temperature increased—Topiramate—epilepsy syndrome	6.19e-05	0.000331	CcSEcCtD
Mometasone—Abdominal pain—Topiramate—epilepsy syndrome	6.19e-05	0.000331	CcSEcCtD
Mometasone—Fluticasone furoate—ABCB1—epilepsy syndrome	6.11e-05	0.0115	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	6.1e-05	0.00476	CbGpPWpGaD
Mometasone—Nausea—Pregabalin—epilepsy syndrome	6.03e-05	0.000322	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—SST—epilepsy syndrome	5.93e-05	0.00463	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	5.93e-05	0.00463	CbGpPWpGaD
Mometasone—Vomiting—Gabapentin—epilepsy syndrome	5.92e-05	0.000316	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	5.91e-05	0.00461	CbGpPWpGaD
Mometasone—Rash—Gabapentin—epilepsy syndrome	5.87e-05	0.000314	CcSEcCtD
Mometasone—Dermatitis—Gabapentin—epilepsy syndrome	5.87e-05	0.000314	CcSEcCtD
Mometasone—Headache—Gabapentin—epilepsy syndrome	5.83e-05	0.000312	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—FOS—epilepsy syndrome	5.68e-05	0.00444	CbGpPWpGaD
Mometasone—Asthenia—Topiramate—epilepsy syndrome	5.62e-05	0.0003	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—CCL2—epilepsy syndrome	5.55e-05	0.00434	CbGpPWpGaD
Mometasone—Pruritus—Topiramate—epilepsy syndrome	5.54e-05	0.000296	CcSEcCtD
Mometasone—Nausea—Gabapentin—epilepsy syndrome	5.53e-05	0.000296	CcSEcCtD
Mometasone—Hydrocortisone—NR3C1—epilepsy syndrome	5.44e-05	0.0103	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TH—epilepsy syndrome	5.44e-05	0.00425	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—SOCS3—epilepsy syndrome	5.39e-05	0.00421	CbGpPWpGaD
Mometasone—Diarrhoea—Topiramate—epilepsy syndrome	5.36e-05	0.000286	CcSEcCtD
Mometasone—Dexamethasone—ABCC2—epilepsy syndrome	5.32e-05	0.01	CrCbGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	5.1e-05	0.00398	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	5.06e-05	0.00395	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—FOS—epilepsy syndrome	5.01e-05	0.00391	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—POMC—epilepsy syndrome	5e-05	0.0039	CbGpPWpGaD
Mometasone—Vomiting—Topiramate—epilepsy syndrome	4.98e-05	0.000266	CcSEcCtD
Mometasone—Rash—Topiramate—epilepsy syndrome	4.94e-05	0.000264	CcSEcCtD
Mometasone—Dermatitis—Topiramate—epilepsy syndrome	4.94e-05	0.000264	CcSEcCtD
Mometasone—Headache—Topiramate—epilepsy syndrome	4.91e-05	0.000262	CcSEcCtD
Mometasone—Methylprednisolone—ABCB1—epilepsy syndrome	4.87e-05	0.00919	CrCbGaD
Mometasone—Triamcinolone—PTGS2—epilepsy syndrome	4.83e-05	0.00912	CrCbGaD
Mometasone—NR3C1—Adipogenesis—MEF2C—epilepsy syndrome	4.76e-05	0.00372	CbGpPWpGaD
Mometasone—Dexamethasone—ABCG2—epilepsy syndrome	4.7e-05	0.00887	CrCbGaD
Mometasone—Nausea—Topiramate—epilepsy syndrome	4.65e-05	0.000249	CcSEcCtD
Mometasone—NR3C1—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	4.57e-05	0.00357	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	4.51e-05	0.00353	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	4.51e-05	0.00353	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	4.5e-05	0.00351	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	4.43e-05	0.00346	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	4.25e-05	0.00332	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—WARS—epilepsy syndrome	4.19e-05	0.00328	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	4.11e-05	0.00321	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—AGT—epilepsy syndrome	4.11e-05	0.00321	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—RELA—epilepsy syndrome	4.1e-05	0.00321	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—JUN—epilepsy syndrome	4.08e-05	0.00319	CbGpPWpGaD
Mometasone—Dexamethasone—NR3C1—epilepsy syndrome	4.06e-05	0.00765	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	3.98e-05	0.0031	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MMP9—epilepsy syndrome	3.97e-05	0.0031	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.96e-05	0.00309	CbGpPWpGaD
Mometasone—Betamethasone—PTGS2—epilepsy syndrome	3.96e-05	0.00747	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	3.93e-05	0.00307	CbGpPWpGaD
Mometasone—Prednisone—ALB—epilepsy syndrome	3.9e-05	0.00737	CrCbGaD
Mometasone—CYP2C8—Biological oxidations—CYP2C19—epilepsy syndrome	3.88e-05	0.00303	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP11A1—epilepsy syndrome	3.85e-05	0.00301	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.83e-05	0.00299	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.8e-05	0.00297	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IL6ST—epilepsy syndrome	3.78e-05	0.00295	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	3.74e-05	0.00292	CbGpPWpGaD
Mometasone—Prednisone—ABCB1—epilepsy syndrome	3.73e-05	0.00703	CrCbGaD
Mometasone—Dexamethasone—CYP2C19—epilepsy syndrome	3.7e-05	0.00698	CrCbGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	3.65e-05	0.00285	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	3.63e-05	0.00284	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—JUN—epilepsy syndrome	3.6e-05	0.00281	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP2D6—epilepsy syndrome	3.48e-05	0.00272	CbGpPWpGaD
Mometasone—Prednisolone—ABCB1—epilepsy syndrome	3.43e-05	0.00648	CrCbGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.43e-05	0.00268	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	3.42e-05	0.00267	CbGpPWpGaD
Mometasone—Betamethasone—ABCB1—epilepsy syndrome	3.37e-05	0.00635	CrCbGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	3.3e-05	0.00258	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.21e-05	0.00251	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—QARS—epilepsy syndrome	3.18e-05	0.00248	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	3.13e-05	0.00244	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	3.01e-05	0.00235	CbGpPWpGaD
Mometasone—Dexamethasone—CYP2D6—epilepsy syndrome	2.74e-05	0.00517	CrCbGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.74e-05	0.00214	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CA13—epilepsy syndrome	2.65e-05	0.00207	CbGpPWpGaD
Mometasone—Hydrocortisone—ABCB1—epilepsy syndrome	2.63e-05	0.00496	CrCbGaD
Mometasone—NR3C1—Gene Expression—EIF2B5—epilepsy syndrome	2.54e-05	0.00198	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—JUNB—epilepsy syndrome	2.31e-05	0.00181	CbGpPWpGaD
Mometasone—Dexamethasone—PTGS2—epilepsy syndrome	2.3e-05	0.00434	CrCbGaD
Mometasone—NR3C1—Gene Expression—TFAM—epilepsy syndrome	2.3e-05	0.00179	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	2.22e-05	0.00173	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	2.21e-05	0.00173	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	2.15e-05	0.00168	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.14e-05	0.00167	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	2.02e-05	0.00158	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PDXK—epilepsy syndrome	2.01e-05	0.00157	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CERS1—epilepsy syndrome	2.01e-05	0.00157	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—L2HGDH—epilepsy syndrome	2.01e-05	0.00157	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GLUD1—epilepsy syndrome	2.01e-05	0.00157	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ADK—epilepsy syndrome	2.01e-05	0.00157	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—FAR1—epilepsy syndrome	2.01e-05	0.00157	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—epilepsy syndrome	2e-05	0.00157	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SNRPE—epilepsy syndrome	1.98e-05	0.00155	CbGpPWpGaD
Mometasone—Dexamethasone—ABCB1—epilepsy syndrome	1.96e-05	0.00369	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	1.88e-05	0.00147	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TNF—epilepsy syndrome	1.86e-05	0.00145	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PNPO—epilepsy syndrome	1.84e-05	0.00144	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—EPM2A—epilepsy syndrome	1.84e-05	0.00144	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NHLRC1—epilepsy syndrome	1.84e-05	0.00144	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GAMT—epilepsy syndrome	1.84e-05	0.00144	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—VDR—epilepsy syndrome	1.84e-05	0.00143	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—QDPR—epilepsy syndrome	1.71e-05	0.00134	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CA4—epilepsy syndrome	1.71e-05	0.00134	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—POMC—epilepsy syndrome	1.7e-05	0.00133	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	1.61e-05	0.00126	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—COX3—epilepsy syndrome	1.61e-05	0.00126	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CACNA2D2—epilepsy syndrome	1.52e-05	0.00119	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—KCNB1—epilepsy syndrome	1.52e-05	0.00119	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PFKL—epilepsy syndrome	1.52e-05	0.00119	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLCO1A2—epilepsy syndrome	1.52e-05	0.00119	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC6A8—epilepsy syndrome	1.52e-05	0.00119	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.49e-05	0.00116	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.48e-05	0.00116	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NEU1—epilepsy syndrome	1.39e-05	0.00109	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—UPB1—epilepsy syndrome	1.39e-05	0.00109	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ATIC—epilepsy syndrome	1.39e-05	0.00109	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—EIF2S1—epilepsy syndrome	1.38e-05	0.00108	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HSD17B4—epilepsy syndrome	1.34e-05	0.00105	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HSPB1—epilepsy syndrome	1.33e-05	0.00104	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPP1R3C—epilepsy syndrome	1.3e-05	0.00101	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GBE1—epilepsy syndrome	1.3e-05	0.00101	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.27e-05	0.000989	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	1.22e-05	0.000952	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	1.19e-05	0.000926	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NT5E—epilepsy syndrome	1.15e-05	0.000902	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALAD—epilepsy syndrome	1.15e-05	0.000902	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—JUNB—epilepsy syndrome	1.11e-05	0.00087	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	1.1e-05	0.000861	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	1.1e-05	0.000861	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	1.08e-05	0.000842	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ADSL—epilepsy syndrome	1.06e-05	0.000825	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GLUL—epilepsy syndrome	1.04e-05	0.000809	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	1.02e-05	0.000794	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	9.51e-06	0.000743	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AQP1—epilepsy syndrome	9.23e-06	0.000721	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SIRT1—epilepsy syndrome	8.97e-06	0.000701	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.87e-06	0.000693	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—VDR—epilepsy syndrome	8.84e-06	0.000691	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—H2AFX—epilepsy syndrome	8.38e-06	0.000655	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	8.35e-06	0.000652	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	8.35e-06	0.000652	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—YWHAZ—epilepsy syndrome	8.09e-06	0.000632	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.78e-06	0.000607	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.62e-06	0.000595	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	6.81e-06	0.000532	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	6.63e-06	0.000518	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	6.59e-06	0.000515	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.54e-06	0.000511	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.97e-06	0.000466	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	5.95e-06	0.000465	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	5.66e-06	0.000442	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—BCHE—epilepsy syndrome	5.64e-06	0.000441	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	5.38e-06	0.00042	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	5.32e-06	0.000416	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TH—epilepsy syndrome	5.3e-06	0.000414	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.22e-06	0.000408	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	4.43e-06	0.000346	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CAT—epilepsy syndrome	4.37e-06	0.000341	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	4.25e-06	0.000332	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GPX1—epilepsy syndrome	3.95e-06	0.000308	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AGT—epilepsy syndrome	3.46e-06	0.00027	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOE—epilepsy syndrome	3.39e-06	0.000265	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—POMC—epilepsy syndrome	2.91e-06	0.000228	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALB—epilepsy syndrome	2.66e-06	0.000208	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—AKT1—epilepsy syndrome	2.44e-06	0.00019	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	2.32e-06	0.000182	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKT1—epilepsy syndrome	1.17e-06	9.13e-05	CbGpPWpGaD
